Commentary
Nesri Padayatchi, Kogieleum
Abstract
The emergence and continued spread of drug resistant forms of tuberculosis (TB) presents an enormous challenge to both TB control programmes and global public health. This is of particular concern in high burden HIV settings where the two epidemics seem to have converged.